Favipiravir in Patients With Early Mild-to-moderate Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Trial
Clinical Infectious Diseases (2023) - Comments
pubmed: 36065065  doi: 10.1093/cid/ciac712  issn: 1058-4838  issn: 1537-6591 

Yoav Golan, Jesus Abraham Simon Campos, Rob Woolson, Donald Cilla, Rodolfo Hanabergh, Yaneicy Gonzales-Rojas, Reynaldo Lopez, Robert Finberg, Armand Balboni